RSNA 2014 

Abstract Archives of the RSNA, 2014


NMS170

Alteration Patterns of Brain Glucose Metabolism: Comparisons of Subjective Memory Impairment, Mild Cognitive Impairment and Healthy Controls

Scientific Posters

Presented on December 2, 2014
Presented as part of NMS-TUA: Nuclear Medicine Tuesday Poster Discussions

Participants

So Hwa Yoon, Presenter: Nothing to Disclose
Yong-An Chung MD, PhD, Abstract Co-Author: Nothing to Disclose
In Uk Song, Abstract Co-Author: Nothing to Disclose
Kijun Kim, Abstract Co-Author: Nothing to Disclose
Jin Kyung Oh MD, Abstract Co-Author: Nothing to Disclose

PURPOSE

Recent clinical and research interests have focused on mild cognitive impairment (MCI) as a prodrome of Alzheimer’s disease (AD) in the prevention of clinical progression. Moreover, some groups have focused on the detection and management of subjective memory impairment (SMI) as the stage that precedes MCI. However, there have been few clinical studies that have examined biomarkers of SMI to date. Therefore, in this study we investigated differences in glucose metabolism as a prodromal marker of dementia in patients with SMI, MCI, and healthy controls using brain FDG-PET.

METHOD AND MATERIALS

We recruited 68 consecutive patients with SMI, 47 patients with MCI, and 42 age-matched healthy subjects. All subjects underwent FDG-PET and detailed neuropsychological testing. FDG-PET images were analyzed using the SPM program.

RESULTS

FDG-PET analysis showed reduced glucose metabolism in the periventricular regions of patients with SMI and in the parietal, precentral frontal, and periventricular regions of patients with MCI compared with healthy controls. Interestingly, hypometabolism on FDG-PET was noted in the parietal and precentral frontal regions in MCI patients compared to SMI patients.

CONCLUSION

Our results suggest that hypometabolism in the periventricular regions as seen on FDG-PET may play a role as a predictive biomarker of pre-dementia, and the extension of reduced glucose metabolism into parietal regions likely reflects progression of cognitive decline.

CLINICAL RELEVANCE/APPLICATION

We investigated differences in glucose metabolism in patients with SMI, MCI, and healthy controls using brain FDG-PET as a potential prodromal biomarker of progression to dementia. An early, accurate diagnosis of prodromal dementia may be valuable since it could allow for proper management and prevent progression to dementia.

Cite This Abstract

Yoon, S, Chung, Y, Song, I, Kim, K, Oh, J, Alteration Patterns of Brain Glucose Metabolism: Comparisons of Subjective Memory Impairment, Mild Cognitive Impairment and Healthy Controls.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14000373.html